Molecular testing no longer belongs exclusively to reference laboratories. The BD MAX System is a fully integrated, automated platform that performs nucleic acid extraction and real-time PCR amplification, supported by a broad IVD assay menu spanning gastrointestinal, healthcare-associated, sexually transmitted and respiratory infections — including MDR-TB and SARS-CoV-2 panels per BD official molecular diagnostics documentation.
The operational case for district and regional hospitals is straightforward: syndromic panels return actionable results in hours instead of culture-confirmed days, directly shortening sepsis pathways, TB initiation times and outbreak responses.
Planning points
- The platform's closed-cartridge workflow means moderate complexity rather than full molecular lab build-out — but biosafety cabinet space and staff PCR training are still required.
- Assay selection should follow your local epidemiology: enteric panels, HAI panels and STI panels each address distinct service gaps.
- Throughput planning should account for batch-based operation; most sites run defined daily batches alongside routine microbiology.
For laboratories moving from send-out testing to in-house molecular diagnostics, the BD MAX System offers one of the lowest-risk entry points available.
Sourcing with KRIMS
KRIMS Meditech Solutions supplies, installs, commissions and maintains this equipment for hospitals and laboratories across Africa, with manufacturer-aligned training and lifecycle support. Request a quotation for configuration, pricing and delivery timelines tailored to your facility.
